SS Innovations Named Outstanding Company Winner at the 2026 Surgical Robotics Industry Awards

About this update from Ss Innovations International Inc.

Company celebrated for advancing global access to its innovative robotic surgery platform FORT LAUDERDALE, Fla., June 30, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company was named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards ("SRIA"). Each year, in the Outstanding Company category, SRIA recognizes a single winning surgical robotics company that demonstrates one or more of the following characteristics: Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, commented, "We are delighted and honored to be named the Outstanding Company winner at this year's prestigious Surgical Robotics Industry Awards. SS Innovations surpassed nine other well-established finalists to win this coveted industry accolade, which reflects our commitment to advancing surgical robotic technologies and democratizing global access to expert surgical care. We believe that surgeons and hospitals are embracing the SSi Mantra surgical robotic system due to its cutting-edge surgical robotic technology, differentiated features, user friendliness, training capabilities, and cost efficiency."  To learn more about the Surgical Robotics Industry Awards visit: www.surgicalroboticsindustryawards.com.      As of June 22, 2026, the cumulative number of multi-specialty procedures completed with the SSi Mantra surgical robotic system totaled 11,719, including 612 cardiac procedures, 175 telesurgeries, and 212 pediatric surgeries. Additionally, approximately 2,100 physicians have been trained on the SSi Mantra, which has been utilized to perform over 170 different types of procedures.  To date, the SSi Mantra has been granted regulatory approval in 14 countries, including: About SS Innovations SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company's product range includes its proprietary "SSi Mantra" surgical robotic system and its comprehensive suite o...

View stock analysis, news, and events for Ss Innovations International Inc.